Le Lézard
Classified in: Health
Subject: SCZ

Avamere Family of Companies Showcases Quality Care in Annual Report


WILSONVILLE, Ore., July 9, 2019 /PRNewswire/ -- The Avamere Family of Companies recently released their annual Quality Report, showcasing company growth and their values in action.

Several organizations make up the Avamere Family of Companies:

The report highlights the many esteemed awards the Avamere Family of Companies received in the last year. Infinity Rehab was named a Great Place to Work, several Avamere Living communities received the Bronze Commitment to Quality Award, and the Portland Business Journal named Avamere as one of Oregon's Most Admired Companies.

In the home health area of the family of companies, many Signature Healthcare at Home locations scored higher than the national average in the depression assessment, fall risk assessment, and several other key process measures.

The report also mentions two groundbreakings of Avamere's newest brand, Ovation by Avamere, a luxury senior living project. Behind this work is another Avamere company, Point Development Company, which is instrumental in the real estate evolution and construction of many Avamere communities.  

Therapy Solutions, which offers therapy professional staffing, experienced significant growth in the last year with a 40 percent increase in clients and vendors.

In addition to compelling data, the report also shares touching employee stories, including their dedication to each other and their patients and residents. Such stories bring the raw numbers to life, painting the true picture of how Avamere enhances the life of every person they serve.

Find out more about the Avamere Family of Companies stories in their annual Quality Report.

About the Avamere Family of Companies

Founded in 1995 and based in Wilsonville, Oregon, the Avamere Family of Companies provides assisted living, independent living, memory care, rehabilitation, home care, transitional care, and more. Today Avamere's diverse companies operate in 248 locations across 18 states with over 8,800 employees. Avamere is proud to be considered one of Oregon's most admired companies as they continue to serve their valued patients and residents. For more information, please visit avamere.com.

Avamere Family of Companies

25115 SW Parkway Ave, Suite B

Wilsonville, OR 97070

For press inquiries, please email press@avamere.com.

Related Images

2019-avamere-quality-report.png
2019 Avamere Quality Report
The Avamere Family of Companies recently released their annual Quality Report, showcasing company growth and their values in action.

Related Links

Website

Facebook

SOURCE Avamere Health Services


These press releases may also interest you

at 03:10
AgraFlora Organics International Inc.  ("AgraFlora" or the "Company") , a growth oriented and diversified international cannabis company, is pleased to announce that Farmako GmbH ("Farmako"), through its wholly owned subsidiary Farmako Limited has...

at 03:00
Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on central nervous system (CNS) disorders, today announces the expansion of its operations in Central Europe with the launch of Neuraxpharm Austria, and the...

at 03:00
The 34th annual iaedptm (International Association of Eating Disorders Professionals) Symposium is just weeks away, and this year's event continues the Symposium's reputation for presenting the latest in new treatments and research concerning eating...

at 03:00
Asymmetrex LLC is part of a new public-private Manufacturing USA initiative, the Advanced Regenerative Manufacturing Institute (ARMI). Headquartered in Manchester, New Hampshire, ARMI is the 12th Manufacturing USA Institute. ARMI brings together a...

at 03:00
Evotec SE and Indivumed GmbH ("Indivumed") today announced that the companies have entered into a new research collaboration to discover and develop first-in-class therapeutics for the treatment of non-small cell lung cancer ("NSCLC"). The final...

at 02:05
POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced the appointment of...



News published on 9 july 2019 at 05:00 and distributed by: